128 related articles for article (PubMed ID: 18262339)
1. What matters - early start or duration of chemotherapy instillation regimens or patient characteristics?
Kaasinen E
Eur Urol; 2008 May; 53(5):882-5; discussion 885-6. PubMed ID: 18262339
[No Abstract] [Full Text] [Related]
2. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
3. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
Jakse G
Prog Clin Biol Res; 1985; 185B():69-78. PubMed ID: 3898142
[No Abstract] [Full Text] [Related]
4. Re: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.
Stewart AB; Mostafid H
J Urol; 2005 Apr; 173(4):1433; author reply 1433. PubMed ID: 15758827
[No Abstract] [Full Text] [Related]
5. The place of intravesical chemotherapy as defined by results of prospective randomized studies (substances and treatment schemes).
Lamm DL; Griffith JG
Prog Clin Biol Res; 1992; 378():43-53. PubMed ID: 1301585
[No Abstract] [Full Text] [Related]
6. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].
Lingnau A; Miller K; Steiner U; Jentzmik F; Weikert S; Schostak M
Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135
[TBL] [Abstract][Full Text] [Related]
7. Perioperative instillation therapy in superficial bladder cancer: is it effective regarding outcome and costs?
Engel RP; Witjes JA
Curr Opin Urol; 2009 Sep; 19(5):511-5. PubMed ID: 19553821
[TBL] [Abstract][Full Text] [Related]
8. The use of intravesical chemotherapy and possibilities for improving its efficacy.
Sylvester RJ
Eur Urol; 2006 Aug; 50(2):233. PubMed ID: 18219714
[No Abstract] [Full Text] [Related]
9. [The intravesical chemotherapy of surface tumors of the bladder].
Matveev BP; Figurin KM; Romanov VA; Burnaz AO
Urol Nefrol (Mosk); 1992; (4-6):13-5. PubMed ID: 1475868
[TBL] [Abstract][Full Text] [Related]
10. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
Sylvester RJ
Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
[No Abstract] [Full Text] [Related]
11. Response of multiple recurrent TaT1 bladder cancer to intravesical apaziquone (EO9): comparative analysis of tumor recurrence rates.
Jain A; Phillips RM; Scally AJ; Lenaz G; Beer M; Puri R
Urology; 2009 May; 73(5):1083-6. PubMed ID: 19232688
[TBL] [Abstract][Full Text] [Related]
12. Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?
Ayres BE; Crew JP;
BJU Int; 2010 Feb; 105 Suppl 2():14-7. PubMed ID: 20089093
[No Abstract] [Full Text] [Related]
13. Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection?
Dobruch J; Herr H
BJU Int; 2009 Jul; 104(2):170-4. PubMed ID: 19493266
[No Abstract] [Full Text] [Related]
14. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
Colombo R
Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
[No Abstract] [Full Text] [Related]
15. [Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules].
Segawa N; Nishida T; Takahara K; Nomi H; Azuma H; Katsuoka Y
Hinyokika Kiyo; 2008 Nov; 54(11):711-6. PubMed ID: 19068724
[TBL] [Abstract][Full Text] [Related]
16. Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C.
Stoehr B; Mueller T; Granig T; Zangerl F; Steiner H
BJU Int; 2008 Dec; 102(11):1556-9. PubMed ID: 18691179
[TBL] [Abstract][Full Text] [Related]
17. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.
Washburn DJ
Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968
[TBL] [Abstract][Full Text] [Related]
18. Risk-adapted use of intravesical chemotherapy.
Lerner SP; Au JL
BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889
[No Abstract] [Full Text] [Related]
19. Re: A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences: I. Berrum-svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang. J Urol 2008; 179: 101-106.
Oosterlinck W; Sylvester R
J Urol; 2008 Nov; 180(5):2255-6; author reply 2256. PubMed ID: 18804803
[No Abstract] [Full Text] [Related]
20. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
Järvinen R; Kaasinen E; Sankila A; Rintala E;
Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
